Translate
About
Rasna Therapeutics Inc (PINK:RASP) — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 3 2018
Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-Mutated Acute Myeloid Leukemia
Apr 20 2017
Rasna Therapeutics Names Dr. Kunwar Shailubhai As New CEO
Apr 12 2017
Rasna Therapeutics Announces Upgrade to OTCQX®
Apr 12 2017
OTC Markets Group Welcomes Rasna Therapeutics to OTCQX
Dec 27 2016
Rasna Therapeutics, Inc. Closes Private Placement of $2 Million
Financials
Revenue
$0
Market Cap
$385.9 K
P/E Ratio
0.00
EPS
0.00